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Amino acid sequencing of a 48/46 kDa glycopeotein from hurndn plantar callus, recognised by antisera raised against the desmosomal cadherins 
DGII/III, has revealed N-terminal homology to the DNA-derived sequence of human and bovine DGII/III. However, a tryptic fragment has homo- 
logy only with a bovine clone. We propose that there are two classes of DGII/III-like molecule, that represented by the bovine cDNA clone and 
the 48/46 kDa protein, a monoclonal antibody against which stains mainly the suprabasal ayers of human epidermis, and that represented by 
the human cDNA clone, identified by a monoclonal antibody which stains uniformly the living layers of the epidermis. 
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1. INTRODUCTION 
Epidermal differentiation (keratinization) involved 
dramatic changes in ultrastructure and biochemical 
composition as cells migrate from the basal layer 
through the spinous and granular layers, to terminally 
differentiate as squames of the stratum corneum. The 
cell surface changes that have been most clearly defined 
in biochemical terms thus far, have been the 
characterisation of the major new proteins, involucrin 
and loricrin, which are synthesised and assembl,ed into 
a cornified submembranous envelope [ 11. We now show 
that subtle yet equally dramatic changes also occur in 
candidate adhesion glycoproteins of the desmosome 
junctions. 
Changes in the morphology of cell adhesions have of 
course already been well characterized during this pro- 
cess [2-41. The desmosome junctions arc prominent in 
the basal layer; they increase in number and change in 
dimensions and electron density before final 
breakdown in the later stages of keratinization. By the 
time the stratum corneum is reached, there is an im- 
permeable and highly protective layer in which 
desmosomes appear to play little part in cell-cell adhe- 
sion. Some changes have been described in the composi- 
tion of the proteins of the desmosomal plaque, which is 
thought to provide a link with the intermediate filament 
network, [5-73, although reports that desmoplakin 
DPII was restricted to stratified epithelia [g] have now 
been refuted [9]. 
As part of a programme to study the molecular basis 
of cell-cell adhesion, we have cloned and sequenced the 
major desmosomal glycoproteins DGI (desmogldn) 
[lo] and DGII/III (desmocollins) [l I] from cDNA 
libraries prepared with cultured human keratinocyte 
mRNA. This has demonstrated that these proteins have 
extensive homology with the cadherin family of cell-cell 
adhesion molecules, and makes both DGI and DGIVIII 
candidate adhesion molecules. DGII and DGIII are 
produced by alternative splicing of a single gene, DSC, 
which we have assigned to chromosome 9 [ 121. Similar 
DGI 1133 and DGII/III [14] clones have also been ob- 
tained from bovine muzzle epidermal cDNA libraries. 
We now report evidence that. a proteir! related to the 
desmosomal glycoproteins DGII/III, but distinct from 
them, is expressed in the later stages of epidermal dif- 
ferentiation, whereas DGII/III themselves are express- 
ed throughout the epidermis. Since DGIVIII are can- 
didate ad.hesion molecules, this finding may presage a 
change in the adhesive capacity of desmosomes as 
keratinization proceeds. 
2. MATERIALS AND METHODS 
2.1. N-terminal sequencing 
ConA binding glycopeptides from plantar callus [15] were resolved 
by SDS-PAGE and transferred to lmmobilon membrane (Millipore) 
using 10 mM 3-[cyclohexylaminol-I-propane sulphonic acid, pH 
I1 ,O, containing 10% methanol. After staining with Amido black and 
destaining the 48146 kDa band was excised and sequenced on an Ap- 
plied Biosystems sequencer (model 473A) using a tangential flow car- 
tridge. 
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ammonium bicarbonate, PI-I 8.5, 0.05% SDS. The protein was recognised by LHSO, and had slightly different 
mobilities (King, unpublished work). 
Therefore to throw more light on the nature of this 
human 48/46 kDa glycopeptide, especially to determine 
whether it was indeed a degradation product of 
DGIVIII, we have performed amino acid sequencing. 
Amino terminal sequence was similar, although not 
identical to the DNA-derived sequence of human DGII 
and DGIII (Fig. 1) [f I], but was more similar to that of 
the bovine clones [14] than of the human clones, even 
though the peptides were from human material. 
Moreover, the sequence of a tryptic fragment from the 
48/46 kDa peptide was not found in the DGII or DGIII 
sequences derived from the human cDNA clones. (The 
closest match is shown in Fig. 1, but since this is at 
residue 579, a pepiide encompassing this and the N- 
terminus would be larger than the size of the 48/46 kDa 
peptide.) We have now, however, found a good match 
of the sequence of this tryptic peptide with the DNA- 
derived sequence of a bovine DGIII clone reported by 
CoIIins et al. [14] (Fig. l), taking into account the 
species difference between the two sequences. Though 
the comparison was less striking, other peptides derived 
from the human 48/46 kDa peptide also matched the 
bovine better than the human DGIII and were found in 
the first 140 N-terminal amino acids. 
We believe, therefore, that the 48146 kDa glycopep- 
tide is a degradation product of a human protein 
analogous to the protein coded by the bovine cDNA 
DGII/III isolated by Collins et al. [14] but actually 
distinct from the protein coded by our human DGII and 
DGIII cDNA clones. The fact that homology between 
the human and bovine amino acid sequences derived 
from the cDNA clones is scattered throughout the 
molecule, rather than arranged in groups, wouid argue 
for these proteins being the result of a gene duplication 
and subsequent evolutionary divergence rather than 
alternative splicing of a single gene. These two 
DGII/lII proteins have: (i) very similar molecular 
weights; (ii) the same domain structures, including 
transmembrane, calcium-binding and cytoplasmic do- 
mains; (iii) the same alternative splicing pattern and the 
same unusual mechanism to insert a stop codon; yet 
identity is a mere 52% at the amino acid levei, far lower 
than would be expected from just inter-species varia- 
tion, especially when the human and bovine DGI are 
identical to the extent of 78%. The level of homology 
digested with 2% (w/w) TPCK-trypsin (Worthington) overnight at 
37°C. The digest was lyophilised twice, redissolved in SDS-PAGE 
sample buffer and resolved using the SDS-PAGE system of Schagger 
and von Jagow [16]. The fragments were transferred to Immobilon 
membrane and sequenced. 
2.3. Sequence comparisons 
Amino acid sequence comparisons were carried out using the 
University of Wisconsin Computer Group programmes [17] running 
on NIMR’s Sun-4 computers. The sequence data used are available 
from EMBL/Genbank/DDBJ under the accession numbers X-56807 
(human DGII/III) [II] and X56966/7/8 (bovine DGII/III) [14]. 
2.4. Indirect immunofhorescence 
Unfixed frozen sections of human breast skin were stained with 
mouse monoclonal antibodies (1 in 5 dilution) as described previously 
[IS] using fluorescein-conjugated rabbit anti-mouse IgG as second an- 
tibody. The monoclonal antibody LHSO (an IgG) was generated 
against the 48146 kDa glycopeptides From plantar callus using stan- 
dard procedures [19]. CEI, and IgG monoclonal generated against 
bovine DGII/III has been described previously [I 11. 
3. RESULTS AND DISCUSSION 
DGIVIII-related glycoproteins have previously been 
identified in the conA-binding material isolated from 
various human epidermal sources [15], by using an- 
tisera raised against a major 78 kDa glycoprotein from 
pig epidermis [I 81. This latter glycoprotein was thought 
to result from degradation of DGIVIII during terminal 
epidermal differentiation [20]. It is recognised by anti- 
DCIVPII polyclonal sera prepared against DGII/PII 
purified from bovine muzzle desmosomes [2I] in both 
immunoblotting and immunoprecipitation analyses, 
and antisera directed against the 78 kDa glycopeptide 
specifically stained desmosomes in immunogold- 
labelling. Likewise, the immunologically related 
glycopeptides of 48/46 kDa from human epidermal 
sources, e.g. plantar callus, have been used to raise sera 
which label desmosomes in immunogold localization. 
Indeed anti-DGIVIII polyclonal sera recognise these 
glycopeptides, and anti-48146 kDa sera produce a 
similar immunoblotting pattern to that produced by 
authentic anti-bovine DGII/III, recognising a 
1 lSkD/lOO kDa glycoprotein. However, although a 
monoclonal antibody raised against the 48146 kDa pro- 
tein, LHSO, and a monoclonal antibody raised against 
bovine DGIVIII (CEl) both recognised bovine protein 
bands in the 115-100 kDa range, those recognised by 
CEl usually appeared more diffuse than the bands 
1 RXAPIPASLMENSLGPP 
I IIII.IIIIIIIIII 
ikntorm.aag I RXAPIPASLMENSLGPF 
I IIII .I:tl;;;:;j 
1 RWAPIPCSLMENSLGPF bovdg2.aag humdg2.aag 149 RWAPIPCSHLENSLGPF 
1 ~;??f~DHFK 
,,,,,,:.I: 
ikltG.aeg 1 ~yjyf"yiPK 
I,,.. f.. 
149 ILQPIPNNPR bovdg2.aag humdg2.aag 579 ILQDVNDNSP 
Fi&. 1. Computer-generated comparisons between the amino acid sequences of the N-terminus (iknterm.aag) and of a tryptic fragment (iklt6,aag) 
of the 48/46 kDa human glycoprotein, with the DNA-derived sequences of a human DGtI cDNA clone [II] (humdg2.aag) and a bovine cDNA 
clone [14] (bovdg2.aag). 
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between the two genes is probably not enough to result 
in cross-hybridization in genomic Southern blots under 
stringent washing conditions, and certainly we saw only 
one band in such hybridizations using a short 118 bp 
probe [ 1 l]. Also we did not see any discrepancies in the 
chromosomal assignments performed using PCR on ro- 
dent-human somatic cell hybrids 1121. In an,y case, if 
there are two genes, they may lie on the same 
chromosomal arm. A precedent for this is the fact that 
DSP, coding for desmoplakin, a major desmosomal 
plaque protein, is assigned to 6p21-ter [ 121, and 
BPAG 1, coding for the hemidesmosomal bullous pem- 
phigoid antigen which has homology to desmoplakin, 
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also maps to chromosome 6, at 6pll-6~12 [22]. It may 
therefore be that gene duplication and subsequent 
evolutionary divergence have played a major role in 
fulfilling the needs for a variety of proteins with differ- 
ing functions in these types of cell junction. What these 
functions are for the two types of DGII/III molecules 
we have begun to examine by determining their location 
with immunofluorescence microscopy using Ivlabs 
specific to these molecules. The results of these ex- 
periments (Fig. 2) show that a monoclonal antibody 
generated against the 48146 kDa glycopeptide produced 
strong staining at the surface of suprabasal cells in 
human epidermis, whereas staining with an anti-bovine 
Fig. 2. Immunofluorescent staining of human skin with (a) LHSO, a monoclonal antibody generated against 48/46 kDa glycopeptides from callus, 
which gives stronger staining in the upper layers of the epidermis and(b) CEl, generated against bovine DCII/III, which gives more uniform stain- 
ing throughout the epidermal layers. The bar is 20 pm. 
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DGII/III rnonoclonal antibody was more uniform 
throughout he living layers of the tissue. The latter an- 
tibody may, of course, be recognising more than one 
type of related molecule, so that the distribution of the 
protein coded by our DGIVIII clones may in fact be 
more restricted than is apparent. It therefore appears 
that differential expression of these distinct types of 
desmosomal cadherins varies throughout he epidermis, 
which implies changes in desmosome-mediated a he- 
sion. Still other DGII/IIP related genes may be unveiled 
by further analysis. 
We propose naming the proteins coded by the 
DGPI/III cDNA cIones reported by us [I 1 J and by Col- 
lins et al. [14] as differentiation-specific variants of 
Desmosomal Cadherins II and III, abbreviated to D- 
cadherins II and III, with DGI being D-cadherin I. 
When the specificity of tissue expression has been more 
rigorously defined, unambiguous nomenclature can be 
developed accordingly. 
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